These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16617391)

  • 21. Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson's disease patients.
    Huang WS; Chiang YH; Lin JC; Chou YH; Cheng CY; Liu RS
    J Nucl Med; 2003 Jul; 44(7):999-1005. PubMed ID: 12843212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine transporter imaging (123)I-FP-CIT (DaTSCAN) SPET in differential diagnosis of dopa-responsive dystonia and young-onset Parkinson's disease.
    Brajkovic LD; Svetel MV; Kostic VS; Sobic-Saranovic DP; Pavlovic SV; Artiko VM; Obradovic VB
    Hell J Nucl Med; 2012; 15(2):134-8. PubMed ID: 22833860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved parkinsonism diagnosis using a partial least squares based approach.
    Segovia F; Gorriz JM; Ramirez J; Alvarez I; Jimenez-Hoyuela JM; Ortega SJ
    Med Phys; 2012 Jul; 39(7):4395-403. PubMed ID: 22830772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of [99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers.
    Mozley PD; Schneider JS; Acton PD; Plössl K; Stern MB; Siderowf A; Leopold NA; Li PY; Alavi A; Kung HF
    J Nucl Med; 2000 Apr; 41(4):584-9. PubMed ID: 10768556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of CT based attenuation correction on quantitative assessment of DaTSCAN ((123)I-Ioflupane) imaging in diagnosis of extrapyramidal diseases.
    Bieńkiewicz M; Górska-Chrzastek M; Siennicki J; Gajos A; Bogucki A; Mochecka-Thoelke A; Płachcińska A; Kuśmierek J
    Nucl Med Rev Cent East Eur; 2008; 11(2):53-8. PubMed ID: 19585455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Artificial neural network classifier for the diagnosis of Parkinson's disease using [99mTc]TRODAT-1 and SPECT.
    Acton PD; Newberg A
    Phys Med Biol; 2006 Jun; 51(12):3057-66. PubMed ID: 16757862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic accuracy of [99mTc]TRODAT-1 SPECT imaging in early Parkinson's disease.
    Chou KL; Hurtig HI; Stern MB; Colcher A; Ravina B; Newberg A; Mozley PD; Siderowf A
    Parkinsonism Relat Disord; 2004 Aug; 10(6):375-9. PubMed ID: 15261880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anatomically standardised 99mTc-ECD brain perfusion SPET allows accurate differentiation between healthy volunteers, multiple system atrophy and idiopathic Parkinson's disease.
    Bosman T; Van Laere K; Santens P
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):16-24. PubMed ID: 12483405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters.
    Fischman AJ; Bonab AA; Babich JW; Palmer EP; Alpert NM; Elmaleh DR; Callahan RJ; Barrow SA; Graham W; Meltzer PC; Hanson RN; Madras BK
    Synapse; 1998 Jun; 29(2):128-41. PubMed ID: 9593103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of instrumentation on DaTSCAN imaging: how feasible is the concept of cross-systems correction factor?
    Zaknun JJ; Schücktanz H; Aichner F
    Q J Nucl Med Mol Imaging; 2007 Jun; 51(2):194-203. PubMed ID: 17220822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing the accuracy and reproducibility of computer-assisted analysis of (123) I-FP-CIT SPECT using BasGan (V2).
    Skanjeti A; Angusti T; Iudicello M; Dazzara F; Delgado Yabar GM; Trevisiol E; Podio V
    J Neuroimaging; 2014; 24(3):257-65. PubMed ID: 23323544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of early-stage Parkinson's disease with 99mTc-TRODAT-1 imaging.
    Huang WS; Lin SZ; Lin JC; Wey SP; Ting G; Liu RS
    J Nucl Med; 2001 Sep; 42(9):1303-8. PubMed ID: 11535717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of a standardized normalization template for statistical parametric mapping analysis of 123I-FP-CIT images.
    Kas A; Payoux P; Habert MO; Malek Z; Cointepas Y; El Fakhri G; Chaumet-Riffaud P; Itti E; Remy P
    J Nucl Med; 2007 Sep; 48(9):1459-67. PubMed ID: 17704252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MR image texture in Parkinson's disease: a longitudinal study.
    Sikiö M; Holli-Helenius KK; Harrison LC; Ryymin P; Ruottinen H; Saunamäki T; Eskola HJ; Elovaara I; Dastidar P
    Acta Radiol; 2015 Jan; 56(1):97-104. PubMed ID: 24413223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of an Objective Striatal Analysis Program for Determining Laterality in Uptake of ¹²³I-Ioflupane SPECT Images: Comparison to Clinical Symptoms and to Visual Reads.
    Kuo PH; Lei HH; Avery R; Krupinski EA; Bauer A; Sherman S; McMillan N; Seibyl J; Zubal GI
    J Nucl Med Technol; 2014 Jun; 42(2):105-8. PubMed ID: 24627411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cardiac sympathetic dysfunction in Parkinson's disease--relationship between results of 123I-MIBG scintigraphy and autonomic nervous function evaluated by the Valsalva maneuver].
    Oka H; Yoshioka M; Morita M; Mochio S; Inoue K
    Rinsho Shinkeigaku; 2003 Aug; 43(8):465-9. PubMed ID: 14658397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Artefactual subcortical hyperperfusion in PET studies normalized to global mean: lessons from Parkinson's disease.
    Borghammer P; Cumming P; Aanerud J; Gjedde A
    Neuroimage; 2009 Apr; 45(2):249-57. PubMed ID: 18718541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early detection of subjective memory impairment in Parkinson's disease using cerebral perfusion SPECT.
    Song IU; Kim JS; Chung SW; Lee KS; Oh JK; Chung YA
    Biomed Mater Eng; 2014; 24(6):3405-10. PubMed ID: 25227051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is iterative reconstruction an alternative to filtered backprojection in routine processing of dopamine transporter SPECT studies?
    Koch W; Hamann C; Welsch J; Pöpperl G; Radau PE; Tatsch K
    J Nucl Med; 2005 Nov; 46(11):1804-11. PubMed ID: 16269593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current status and future challenges of brain imaging with (18)F-DOPA PET for movement disorders.
    Calabria FF; Calabria E; Gangemi V; Cascini GL
    Hell J Nucl Med; 2016; 19(1):33-41. PubMed ID: 26929938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.